Symbol="LUMO"
AssetType="Common Stock"
Name="Lumos Pharma Inc"
Description="Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies. The company is headquartered in Austin, Texas."
CIK="1126234"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2503 SOUTH LOOP DRIVE, SUITE 5100, AMES, IA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="27538000"
EBITDA="-32298000"
PERatio="None"
PEGRatio="None"
BookValue="6.42"
DividendPerShare="0"
DividendYield="0"
EPS="-3.76"
RevenuePerShareTTM="0.252"
ProfitMargin="0"
OperatingMarginTTM="-15.38"
ReturnOnAssetsTTM="-0.258"
ReturnOnEquityTTM="-0.457"
RevenueTTM="2103000"
GrossProfitTTM="1523000"
DilutedEPSTTM="-3.76"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="5.22"
AnalystTargetPrice="18.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="22.45"
PriceToBookRatio="0.405"
EVToRevenue="1.11"
EVToEBITDA="1.564"
Beta="0.566"
num_52WeekHigh="9.56"
num_52WeekLow="2.95"
num_50DayMovingAverage="3.57"
num_200DayMovingAverage="4.277"
SharesOutstanding="8170500"
DividendDate="2020-03-19"
ExDividendDate="None"
symbol="LUMO"
open="3.26"
high="3.37"
low="3.12"
price="3.37"
volume="12076.00"
latest_trading_day="2023-07-28"
previous_close="3.34"
change="0.03"
change_percent="0.9102%"
aroon_positive_momentum_days="59"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="59"
Volume_recent_avg="19138"
Change_recent_avg="-0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.35"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="59"
Aroon_momentum_negative="41"
image_negative_thumbnail_id_1="1115"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0148.jpeg"
image_negative_thumbnail_id_2="510"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0095.jpeg"
image_neutral_thumbnail_id_1="595"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0004.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="975"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_positive_thumbnail_id_2="985"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0147.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
